Skip to Content

Fleury SA FLRY3

Rating as of

Morningstar’s Analysis

Currency in
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Fleury SA is engaged in rendering medical services in the diagnostic, treatment, clinical analysis, health management, and medical care areas. The company operates through three business segments namely Diagnostic medicine, Integrated medicine, and Dental. In addition, it is also involved in the development of the medical profession and fosters research and studies for the scientific progress of medicine.

Avenida General Valdomiro de Lima, 508
Jabaquara, SP, 4344903, Brazil
T +55 1150147413
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings Dec 31, 2020
Fiscal Year End Dec 31, 2021
Stock Type
Employees 11,200